ELASTOVISC Trademark

Trademark Overview


On Tuesday, June 18, 2024, a trademark application was filed for ELASTOVISC with the United States Patent and Trademark Office. The USPTO has given the ELASTOVISC trademark a serial number of 98606198. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, January 21, 2025. This trademark is owned by Matrix Biology Institute. The ELASTOVISC trademark is filed in the Chemical Products category with the following description:

Sodium hyaluronate for use in the manufacture of medical devices
elastovisc

General Information


Serial Number98606198
Word MarkELASTOVISC
Filing DateTuesday, June 18, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, January 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesSodium hyaluronate for use in the manufacture of medical devices

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, June 18, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMatrix Biology Institute
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEdgewater, NJ 07020

Trademark Events


Event DateEvent Description
Tuesday, June 18, 2024NEW APPLICATION ENTERED
Wednesday, January 8, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 10, 2025ASSIGNED TO EXAMINER
Tuesday, January 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 21, 2025NON-FINAL ACTION E-MAILED
Tuesday, January 21, 2025NON-FINAL ACTION WRITTEN